Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells

Journal of Immunological Methods

Volumn 314, Issue 1-2, 2006, Pages 54-66

  Naota, Hiroaki ^a   Miyahara, Yoshihiro ^a   Okumura, Satoshi ^a   Kuzushima, Kiyotaka ^b   Akatsuka, Yoshiki ^b   Hiasa, Atsunori ^a   Kitano, Shigehisa ^a   Takahashi, Toshitada ^b   Yuta, Atsushi ^a   Majima, Yuichi ^a   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

CD4+ PHA blasts; CD8+ T cell; HLA B*4002; MAGE A4; Messenger RNA

Indexed keywords

ANTIGEN; B7 ANTIGEN; CANCER TESTIS ANTIGEN; CD86 ANTIGEN; EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELANOMA ANTIGEN 4; MELANOMA ANTIGEN 4 [223-231]; MESSENGER RNA; PHYTOHEMAGGLUTININ; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; LYMPHOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; ELECTROPORATION; EPITOPES; GREEN FLUORESCENT PROTEINS; HLA-A ANTIGENS; MICE; NEOPLASM PROTEINS; PEPTIDES; PHYTOHEMAGGLUTININS; RNA, MESSENGER; TRANSDUCTION, GENETIC;

EID: 33746905935     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.05.009     Document Type: Article

References (45)

1. Ackerman A.L., and Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5 (2004) 678
2. Akatsuka Y., Goldberg T.A., Kondo E., Martin E.G., Obata Y., Morishima Y., Takahashi T., and Hansen J.A. Efficient cloning and expression of HLA class I cDNA in human B-lymphoblastoid cell lines. Tissue Antigens 59 (2002) 502
3. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94
4. Atanackovic D., Matsuo M., Ritter E., Mazzara G., Ritter G., Jager E., Knuth A., Old L.J., and Gnjatic S. Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC. J. Immunol. Methods 278 (2003) 57
5. Bonehill A., Heirman C., Tuyaerts S., Michiels A., Breckpot K., Brasseur F., Zhang Y., Van Der Bruggen P., and Thielemans K. Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules. J. Immunol. 172 (2004) 6649
6. Bonini C., Lee S.P., Riddell S.R., and Greenberg P.D. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells. J. Immunol. 166 (2001) 5250
7. Cao K., Hollenbach J., Shi X., Shi W., Chopek M., and Fernandez-Vina M.A. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum. Immunol. 62 (2001) 1009
8. Coulie P.G., Brichard V., Van Pel A., Wolfel T., Schneider J., Traversari C., Mattei S., De Plaen E., Lurquin C., Szikora J.P., Renauld J.C., and Boon T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180 (1994) 35
9. Dani A., Chaudhry A., Mukherjee P., Rajagopal D., Bhatia S., George A., Bal V., Rath S., and Mayor S. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment. J. Cell Sci. 117 (2004) 4219
10. Davis I.D., Chen W., Jackson H., Parente P., Shackleton M., Hopkins W., Chen Q., Dimopoulos N., Luke T., Murphy R., Scott A.M., Maraskovsky E., McArthur G., MacGregor D., Sturrock S., Tai T.Y., Green S., Cuthbertson A., Maher D., Miloradovic L., Mitchell S.V., Ritter G., Jungbluth A.A., Chen Y.T., Gnjatic S., Hoffman E.W., Old L.J., and Cebon J.S. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10697
11. De Plaen E., De Backer O., Arnaud D., Bonjean B., Chomez P., Martelange V., Avner P., Baldacci P., Babinet C., Hwang S.Y., Knowles B., and Boon T. A new family of mouse genes homologous to the human MAGE genes. Genomics 55 (1999) 176
12. Gilboa E., and Vieweg J. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol. Rev. 199 (2004) 251
13. Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol. Rev. 157 (1997) 125
14. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., Parish I.A., Davey G.M., Wilson N.S., Carbone F.R., and Villadangos J.A. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199 (2004) 9
15. Heiser A., Coleman D., Dannull J., Yancey D., Maurice M.A., Lallas C.D., Dahm P., Niedzwiecki D., Gilboa E., and Vieweg J. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J. Clin. Invest. 109 (2002) 409
16. Howarth M., and Elliott T. The processing of antigens delivered as DNA vaccines. Immunol. Rev. 199 (2004) 27
17. Ikuta Y., Katayama N., Wang L., Okugawa T., Takahashi Y., Schmitt M., Gu X., Watanabe M., Akiyoshi K., Nakamura H., Kuribayashi K., Sunamoto J., and Shiku H. Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy. Blood 99 (2002) 3717
18. Ikuta Y., Okugawa T., Furugen R., Nagata Y., Takahashi Y., Wang L., Ikeda H., Watanabe M., Imai S., and Shiku H. A HER2/NEU-derived peptide, a K(d)-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes. Int. J. Cancer 87 (2000) 553
19. Jager E., Chen Y.T., Drijfhout J.W., Karbach J., Ringhoffer M., Jager D., Arand M., Wada H., Noguchi Y., Stockert E., Old L.J., and Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187 (1998) 265
20. Janetzki S., Schaed S., Blachere N.E., Ben-Porat L., Houghton A.N., and Panageas K.S. Evaluation of Elispot assays: influence of method and operator on variability of results. J. Immunol. Methods 291 (2004) 175
21. Kawaguchi G., Kato N., Kashiwase K., Karaki S., Kohsaka T., Akaza T., Kano K., and Takiguchi M. Structural analysis of HLA-B40 epitopes. Hum. Immunol. 36 (1993) 193
22. Kawakami Y., Eliyahu S., Delgado C.H., Robbins P.F., Rivoltini L., Topalian S.L., Miki T., and Rosenberg S.A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3515
23. Kondo E., Topp M.S., Kiem H.P., Obata Y., Morishima Y., Kuzushima K., Tanimoto M., Harada M., Takahashi T., and Akatsuka Y. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. J. Immunol. 169 (2002) 2164
24. *2402-restricted Epstein-Barr virus-specific CD8+ T cells. Blood 101 (2003) 1460
25. Larsson M., Fonteneau J.F., Somersan S., Sanders C., Bickham K., Thomas E.K., Mahnke K., and Bhardwaj N. Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur. J. Immunol. 31 (2001) 3432
26. Li X., Zhao X., Fang Y., Jiang X., Duong T., Fan C., Huang C.C., and Kain S.R. Generation of destabilized green fluorescent protein as a transcription reporter. J. Biol. Chem. 273 (1998) 34970
27. Lin L., Tokunaga K., Ogawa A., Ishikawa Y., Kashiwase K., Akaza T., Kuwata S., Tadokoro K., and Juji T. Genotyping and association analysis of HLA-B61 in Japanese. Hum. Immunol. 37 (1993) 95
28. Martelange V., De Smet C., De Plaen E., Lurquin C., and Boon T. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res. 60 (2000) 3848
29. Miyahara Y., Naota H., Wang L., Hiasa A., Goto M., Watanabe M., Kitano S., Okumura S., Takemitsu T., Yuta A., Majima Y., Lemonnier F.A., Boon T., and Shiku H. Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE. Clin. Cancer Res. 11 (2005) 5581
30. Ogawa A., Tokunaga K., Lin L., Kashiwase K., Tanaka H., Herrero M.J., Vilches C., Park M.H., Jia G.J., Chimge N.O., Sideltseva E.W., Ishikawa Y., Akaza T., Tadokoro K., and Juji T. Diversity of HLA-B61 alleles and haplotypes in East Asians and Spanish Gypsies. Tissue Antigens 51 (1998) 356
31. Okugawa T., Ikuta Y., Takahashi Y., Obata H., Tanida K., Watanabe M., Imai S., Furugen R., Nagata Y., Toyoda N., and Shiku H. A novel human HER2-derived peptide homologous to the mouse K(d)-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals. Eur. J. Immunol. 30 (2000) 3338
32. Power C.A., Grand C.L., Ismail N., Peters N.C., Yurkowski D.P., and Bretscher P.A. A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFNgamma-producing T cells. J. Immunol. Methods 227 (1999) 99
33. Rickinson A.B., and Moss D.J. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15 (1997) 405
34. Riddell S.R., and Greenberg P.D. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods 128 (1990) 189
35. Robbins P.F., el-Gamil M., Kawakami Y., Stevens E., Yannelli J.R., and Rosenberg S.A. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54 (1994) 3124
36. Scanlan M.J., Gure A.O., Jungbluth A.A., Old L.J., and Chen Y.T. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 188 (2002) 22
37. Schultze J.L., Michalak S., Seamon M.J., Dranoff G., Jung K., Daley J., Delgado J.C., Gribben J.G., and Nadler L.M. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J. Clin. Invest. 100 (1997) 2757
38. St George J.A. Gene therapy progress and prospects: adenoviral vectors. Gene Ther. 10 (2003) 1135
39. Stevenson F.K., Rice J., Ottensmeier C.H., Thirdborough S.M., and Zhu D. DNA fusion gene vaccines against cancer: from the laboratory to the clinic. Immunol. Rev. 199 (2004) 156
40. Subklewe M., Paludan C., Tsang M.L., Mahnke K., Steinman R.M., and Munz C. Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells. J. Exp. Med. 193 (2001) 405
41. Tsuchida T., Parker K.C., Turner R.V., McFarland H.F., Coligan J.E., and Biddison W.E. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 10859
42. Van Der Bruggen P., Zhang Y., Chaux P., Stroobant V., Panichelli C., Schultz E.S., Chapiro J., Van Den Eynde B.J., Brasseur F., and Boon T. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol. Rev. 188 (2002) 51
43. Van Tendeloo V.F., Ponsaerts P., Lardon F., Nijs G., Lenjou M., Van Broeckhoven C., Van Bockstaele D.R., and Berneman Z.N. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98 (2001) 49
44. von Bergwelt-Baildon M.S., Vonderheide R.H., Maecker B., Hirano N., Anderson K.S., Butler M.O., Xia Z., Zeng W.Y., Wucherpfennig K.W., Nadler L.M., and Schultze J.L. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood 99 (2002) 3319
45. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., Jones T.R., Hobart P., Margalith M., Ng J., Weiss W.R., Sedegah M., de Taisne C., Norman J.A., and Hoffman S.L. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282 (1998) 476